LITTLETON, Colo., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for ...
The DNA and MRNA Appliance Systems provide a breakthrough solution for those suffering from sleep apnea, allowing them to achieve better health and improved quality of life." For more information ...
Vivos Therapeutics, Inc. has announced the publication of positive results from a multicenter clinical trial on its Daytime-Nighttime Appliance (DNA) for treating obstructive sleep apnea (OSA) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback